Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Rapid-Acting NMDA Antagonist for Treatment of Adolescent Depression and Anxiety Disorders

NCT02579928 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT02579928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02579928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Rapid-Acting NMDA Antagonist for Treatment of Adolescent Depression and Anxiety Disorders
Lead sponsor
Yale University
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2015
Completion date
September 30, 2019
Enrollment
17 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorder, major depressive disorder